News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Schering AG, (SHR) Combinature Biopharm AG In Dermatology Research Pact



10/19/2005 5:09:29 PM

Schering AG (NYSE:SHR - News) and Combinature Biopharm AG, Germany, have signed a research agreement to apply Combinature's proprietary combinatorial biosynthesis technology to generate derivatives of one of Schering's lead compounds in the area of dermatology.

Read at Dow Jones


comments powered by Disqus
Dow Jones
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES